The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsiamet Res Regulatory News (ARS)

Share Price Information for Asiamet Res (ARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.30
Ask: 1.45
Change: 0.025 (1.85%)
Spread: 0.15 (11.538%)
Open: 1.35
High: 1.43
Low: 1.35
Prev. Close: 1.35
ARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2021 Annual Report & Financial Statements

4 May 2022 11:00

RNS Number : 2927K
Asiamet Resources Limited
04 May 2022
 

4 May 2022

 

 

2021 Annual Report & Financial Statements

 

Asiamet Resources Limited ("Asiamet" or the "Company") is pleased to present its audited financial statements for the 12 months ended 31 December 2021 ("Financial Statements") as extracted from the Company's 2021 Annual Report which is now available on the Company website at www.asiametresources.com and will be provided to shareholders who have requested a printed or electronic copy.

The Financial Statements are set out below and should be read in conjunction with the 2021 Annual Report which contains the notes to the Financial Statements.

All dollars in the report are US$ unless otherwise stated.

2021 Financial and Operational Highlights Include:

· Approval of a key environmental permit (AMDAL) for the BKM Project.

· Completed a capital placing, raising gross proceeds of approximately $14.0 million in February 2021.

· Appointment of Eva Armila Djauhari as Non-Executive Director.

· Appointment of Andrew Neale as General Manager for the BKM Project.

· Entered into a Heads of Agreement with PT Delta Dunia Makmur Tbk. ("DOID"), this agreement allows DOID to earn up to 51% interest in the KSK CoW by contributing up to $50 million towards development of the BKM copper mine.

· Commenced a resource extension and exploration drilling program at BKZ project.

 

Key Subsequent Events Include:

· Extension of the exclusivity period to allow DOID to complete their due diligence.

· Appointment of Mr Darryn McClelland as a Chief Executive Officer ("CEO"), commencing 13 June 2022.

ON BEHALF OF THE BOARD OF DIRECTORS

Antony (Tony) Manini, Executive Chairman

For further information, please contact:

-Ends-

Tony ManiniExecutive Chairman, Asiamet Resources LimitedEmail: tony.manini@asiametresources.com

 

FlowComms Limited - Investor Relations

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com 

Asiamet Resources Nominated AdviserRFC Ambrian Limited

Bhavesh Patel / Stephen Allen

Telephone: +44 (0)20 3440 6800

Email: Bhavesh.Patel@rfcambrian.com / Stephen.Allen@rfcambrian.com 

 

Optiva Securities LimitedChristian Dennis

Telephone: +44 20 3137 1903

Email: Christian.Dennis@optivasecurities.com

 

 

 

Follow us on twitter @AsiametTweets

 

FORWARD-LOOKING STATEMENT

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

 

 

Consolidated Statement of Financial Position

As at 31 December 2021

 

 

 

 

2021

2020

 

 

 $'000

 $'000

Assets

 

 

Current assets

 

 

 

Cash

9,060

 1,179

 

Receivables and other assets

33

 4

 

 

9,093

 1,183

 

Assets classified as held for sale

-

 125

 

 

9,093

1,308

Non-current assets

 

 

 

Plant and equipment

60

 39

 

Right-of-use assets

7

 3

 

Receivables and other assets

71

 5

 

 

138

 47

Total assets

9,231

1,355

Liabilities and Equity

 

 

Current liabilities

 

 

 

Trade and other payables

537

 391

 

Provisions

285

 253

 

Lease liabilities

159

 278

 

 

981

 922

 

Liabilities directly associated with the assets classified as held for sale

-

 753

 

 

981

1,675

Non-current liabilities

 

 

 

Provisions for employee service entitlements

794

81

 

1,775

1,756

 

 

 

Equity

 

 

 

Share capital

19,393

 14,752

 

Equity reserves

65,975

 56,661

 

Other comprehensive income

49

 83

 

Accumulated deficit

(74,708)

 (68,644)

 

Other reserves

(3,246)

 (3,246)

 

Parent entity interest

7,463

 (394)

 

Non-controlling interest

(7)

 (7)

 

 

7,456

(401)

Total liabilities and equity

9,231

1,355

 

 

 

 

Consolidated Statement of Comprehensive Loss

For the year ended 31 December 2021

 

 

 

 

2021

 

2020 Restated*

 

 

 

 $'000

 $'000

Expenses

 

 

 

 

Exploration and evaluation

 

(2,414)

 (1,276)

 

Employee benefits

 

(2,147)

 (1,837)

 

Consultants

 

(81)

 (239)

 

Legal and Company Secretarial

 

(142)

 (237)

 

Accounting and audit

 

(46)

 (52)

 

General and administrative

 

(287)

 (286)

 

Depreciation

 

(45)

 (81)

 

Share-based compensation

 

(600)

 (175)

 

 

 

(5,762)

 (4,183)

Other items

 

 

 

 

Foreign exchange (loss)/gain

 

(169)

 339

 

Interest income

 

-

 2

 

Finance costs

 

(18)

 (27)

 

Impairment expense

 

(117)

 (335)

 

Other income

 

2

 71

 

 

 

(302)

 50

Net loss before tax

 

(6,064)

 (4,133)

Income tax expense

 

-

 -

Net loss for the year

 

(6,064)

(4,133)

Item that may not be reclassified subsequently

 

 

 

to profit or loss:

 

 

 

 

Actuarial (loss)/gain on employee service entitlements

 

(34)

9

Total comprehensive loss for the year

 

(6,098)

(4,124)

 

 

 

 

Net loss attributable to:

 

 

 

 

Equity holders of the parent

 

(5,878)

 (4,040)

 

Non-controlling interests

 

(186)

 (93)

Total comprehensive loss attributable to:

 

 

 

 

Equity holders of the parent

 

(5,912)

 (4,031)

 

Non-controlling interests

 

(186)

 (93)

 

 

 

 

 

Basic and diluted loss per common share (cents per share)

 

(0.33)

(0.29)

 

 

 

 

 

Weighted average number of shares outstanding (thousands)

 

1,859,029

1,414,666

 

* Following the termination of the Sale Purchase Agreement with PT Wasesa Indo Nusa on 25 January 2021, the Indokal Group was reclassified from a held for sale group and discontinued operations.

Consolidated Statement of Cash Flows

For the year ended 31 December 2021

 

 

2021

 

2020 Restated*

 

 $'000

 $'000

Operating activities

 

 

Loss before tax

(6,064)

(4,133)

Adjustments for:

 

 

Depreciation

45

81

Share-based compensation

600

175

Net foreign exchange gain

(23)

(18)

Impairment expenses

117

335

Finance costs

18

27

Movements in provisions

228

271

Changes in working capital:

 

 

Receivables and other assets

(133)

34

Trade and other payables

(117)

258

 

(5,329)

(2,970)

Interest payments

(18)

(27)

Refund of security deposit

-

15

Net cash flows used in operating activities

(5,347)

(2,982)

 

 

 

Investing activity

 

 

Purchases of property, plant and equipment

(23)

(4)

Net cash flows used in investing activities

(23)

(4)

 

 

 

Financing activities

 

 

Payment of principal portion of lease liabilities

(111)

(80)

Proceeds from related party loans

-

380

Repayment of related party loans

-

(257)

Proceeds from equity raising

14,089

3,775

Equity raising costs

(734)

(64)

Net cash flows from financing activities

13,244

3,754

Increase in cash

7,874

768

Cash at beginning of the year

1,186

418

Cash at end of the year

9,060

1,186

 

 

 

 

 

* Following the termination of the Sale Purchase Agreement with PT Wasesa Indo Nusa on 25 January 2021, the Indokal Group was reclassified from a held for sale group and discontinued operations.

Consolidated Statement of Changes in Equity

For the year ended 31 December 2021

 

 

 

 

 

 

 

Total equity

 

 

 

 

 

 

Other

 

 

attributable

Non-

 

 

 

 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

 

 

 

capital

reserves

income

deficit

reserves

parent

interests

Total

 

 

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2020

10,969

56,435

74

 (64,511)

 (3,246)

 (279)

 (7)

 (286)

 

 

 

 

 

 

 

 

 

 

Loss for the year

 -

 -

 -

 (4,040)

 -

 (4,040)

 (93)

 (4,133)

 

Other comprehensive income

 -

 -

 9

 -

 -

 9

 -

 9

 

Total comprehensive income/(loss)

-

-

9

 (4,040)

-

 (4,031)

(93)

 (4,124)

 

 

 

 

 

 

 

 

 

 

Transactions with owners in their capacity

as owners

 

 

 

 

 

 

 

 

Equity raising

 3,617

158

 -

 -

 -

 3,775

 -

 3,775

 

Related party loans converted to equity

117

6

-

-

-

123

-

123

 

Equity raising costs

 -

 (64)

 -

 -

 -

 (64)

 -

 (64)

 

Reclassify shares issued to directors

 49

 (49)

 -

 -

 -

 -

 -

 -

 

Share-based compensation

 -

 175

 -

 -

 -

 175

 -

 175

 

Contribution by parent in NCI

 -

 -

 -

 (93)

 -

 (93)

 93

 -

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2020

14,752

 56,661

83

 (68,644)

 (3,246)

 (394)

(7)

(401)

                  

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2021

 

 

 

 

 

 

 

 

 

Total equity

 

 

 

 

 

 

Other

 

 

attributable

Non-

 

 

 

 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

 

 

 

capital

reserves

income

deficit

reserves

parent

interests

Total

 

 

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2021

14,752

 56,661

 83

 (68,644)

 (3,246)

 (394)

 (7)

 (401)

 

 

 

 

 

 

 

 

 

 

 

Loss for the year

-

-

-

(5,878)

-

(5,878)

(186)

(6,064)

 

Other comprehensive loss

-

-

(34)

-

-

(34)

-

(34)

Total comprehensive loss

-

-

(34)

(5,878)

-

(5,912)

(186)

(6,098)

 

 

 

 

 

 

 

 

 

 

Transactions with owners in their capacity

as owners

 

 

 

 

 

 

 

 

 

Equity raising

4,574

9,515

-

-

-

14,089

-

14,089

 

Equity raising costs

-

(734)

-

-

-

(734)

-

(734)

 

Reclassify shares issued to directors

52

(52)

-

-

-

-

 

-

 

Share-based compensation

15

585

-

-

-

600

-

600

 

Contribution by parent in NCI

-

-

-

(186)

-

(186)

186

-

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2021

19,393

65,975

49

(74,708)

(3,246)

7,463

(7)

7,456

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR GCGDUDUGDGDS
Date   Source Headline
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Jan 20211:00 pmRNSDeal Update – Sale Process
4th Jan 20219:00 amRNSImportant Environmental Approval Received for BKM
30th Dec 20204:30 pmRNSNotice of General Meeting
24th Dec 20208:30 amRNSSale and Purchase Agreement Executed
11th Dec 202011:00 amRNSCorporate Update – KSK Sale Process
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
13th Oct 202010:09 amRNSMedia and Presentation Links
8th Oct 20204:41 pmRNSSecond Price Monitoring Extn
8th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20202:06 pmRNSSecond Price Monitoring Extn
8th Oct 20202:00 pmRNSPrice Monitoring Extension
8th Oct 202011:05 amRNSSecond Price Monitoring Extn
8th Oct 202011:00 amRNSPrice Monitoring Extension
8th Oct 20209:05 amRNSSecond Price Monitoring Extn
8th Oct 20209:00 amRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSHeads of Agreement Signed for KSK
7th Sep 20209:35 amRNSAppointment of Crowe U.K. LLP as Auditor
28th Aug 20208:05 amRNSAppointment of Chief Financial Officer
20th Aug 20207:02 amRNS2020 Interim Financial Statements
13th Aug 202010:30 amRNSIssue of Director Performance Rights
7th Aug 202011:49 amRNSLink to Investor Call and Q&A
17th Jul 20201:32 pmRNSAsiamet Responds to Media Article
3rd Jul 202012:05 pmRNSAGM 2020 Q&A Session
30th Jun 20205:25 pmRNSResult of AGM
26th Jun 202010:50 amRNSCorporate Update
22nd Jun 20203:55 pmRNSAnnual General Meeting Update
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
28th May 20204:00 pmRNSNotice of Annual General Meeting
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:45 amRNSCorporate Update
15th May 20209:05 amRNSSecond Price Monitoring Extn
15th May 20209:00 amRNSPrice Monitoring Extension
15th May 20207:00 amRNSAsiamet Receives Key Approval for BKM Project
5th May 20207:10 amRNS2019 Annual Report & Financial Statements
28th Apr 20209:01 amRNSKSK Receives Key Exploration Permit
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:00 pmRNSCorrection of Admission Date
25th Mar 202010:22 amRNSStrategic Investment and Development Partner
25th Mar 20209:05 amRNSSecond Price Monitoring Extn
25th Mar 20209:00 amRNSPrice Monitoring Extension
13th Mar 20209:46 amRNSAsiamet Business Update
10th Mar 20202:05 pmRNSSecond Price Monitoring Extn
10th Mar 20202:00 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSRelocates Head Office to Jakarta, Indonesia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.